CONTROLS AND PROCEDURES
−Removed: Evaluation of Disclosure Controls and Procedures
−Removed: Our management, with the participation of our
−Removed: principal executive officer and principal financial officer, evaluated the effectiveness of our “disclosure controls and procedures”
−Removed: (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) as of December 31, 2021, the end of the period covered by this Annual Report
−Removed: on Form 10-K.
−Removed: The term “disclosure controls and procedures” as defined in Rules 13a-15(e) and 15d-15(e)
−Removed: under the Exchange Act, means controls and other procedures of a company that are designed to ensure
−Removed: that information required to be disclosed by a company in the reports that it files under the Exchange Act is recorded, processed, summarized
−Removed: and reported, within the time periods specified in the SEC’s rules and forms.
−Removed: Disclosure controls and procedures include, without
−Removed: limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it
−Removed: files under the Exchange Act is accumulated and communicated to a company’s management, including its principal executive officer
−Removed: and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.
−Removed: In designing and evaluating
−Removed: the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated,
−Removed: cannot provide absolute assurance that the objectives of the controls system are met, and no evaluation of controls can provide absolute
−Removed: assurance that all control issues and instances of fraud, if any, within a company have been detected.
−Removed: Based on the evaluation of our disclosure
−Removed: controls and procedures as of December 31, 2021, our management , with the participation of our principal executive
−Removed: officer and principal financial officer has concluded that, based on such evaluation, as of the end of the period covered by this Annual
−Removed: Report on Form 10-K, our disclosure controls and
−Removed: procedures were not effective due to the material weakness described below.
−Removed: However, our management, including our principal executive
−Removed: officer and principal financial officer, has concluded that, notwithstanding the identified material weakness in our internal control
−Removed: over financial reporting, the financial statements in this Annual Report on Form 10-K fairly present, in all material respects, our financial condition,
−Removed: results of operations and cash flows for the periods presented in conformity with U.S.
−Removed: Material Weakness in Internal Controls Over
−Removed: Financial Reporting
−Removed: We identified a material weakness in our internal
−Removed: control over financial reporting that exists as of December 31, 2021.
−Removed: A material weakness is a deficiency, or a combination of deficiencies,
−Removed: in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of our annual
−Removed: or interim financial statements will not be prevented or detected on a timely basis.
−Removed: We determined that we had a material weakness because, due to our small size, and our limited number of personnel, we did not
−Removed: have in place an effective internal control environment with formal processes and procedures, including journal entry processing and review,
−Removed: to allow for a detailed review of accounting transactions that would identify errors in a timely manner.
−Removed: Notwithstanding the material weaknesses in
−Removed: our internal control over financial reporting, we have concluded that the consolidated financial statements included in this Annual
−Removed: Report on Form 10-K fairly present, in all material respects, our financial position, results of operations and cash flows for the
−Removed: periods presented in conformity with accounting principles generally accepted in the United States of America.
−Removed: Management’s Plan to Remediate the Material
−Removed: With the oversight of senior management, we implemented
−Removed: remediation steps in 2021 including addition of accounting consultants and continue to evaluate and implement
−Removed: procedures that will strengthen our internal controls.
−Removed: While we believe these measures will remediate the material weakness identified and strengthen our internal
−Removed: control over financial reporting, the implemented and enhanced controls have not operated for a sufficient period of time to demonstrate
−Removed: that the material weakness is remediated.
−Removed: We are committed to continuing to improve
−Removed: our internal control processes and will continue to diligently review our financial reporting controls and procedures.
+Added: of Disclosure Controls and Procedures
+Added: management, with the participation of our principal executive officer and principal financial officer, evaluated the effectiveness of
+Added: our “disclosure controls and procedures” as of December 31, 2022, the end of the period covered by this Annual Report on
+Added: The term “disclosure controls and procedures” as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act
+Added: means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in
+Added: the reports that it files under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in
+Added: the SEC’s rules and forms.
+Added: Disclosure controls and procedures include, without limitation, controls and procedures designed to
+Added: ensure that information required to be disclosed by a company in the reports that it files under the Exchange Act is accumulated and
+Added: communicated to a company’s management, including its principal executive officer and principal financial officer, as appropriate
+Added: to allow timely decisions regarding required disclosure.
+Added: In designing and evaluating the disclosure controls and procedures, management
+Added: recognizes that any controls and procedures, no matter how well designed and operated, cannot provide absolute assurance that the objectives
+Added: of the controls system are met, and no evaluation of controls can provide absolute assurance that all control issues and instances of
+Added: fraud, if any, within a company have been detected.
+Added: Based on the evaluation of our disclosure controls and procedures as of December
+Added: 31, 2022, our management, with the participation of our principal executive officer and
+Added: principal financial officer has concluded that, based
+Added: on such evaluation, as of the end of the period covered by this Annual Report on Form 10-K ,
+Added: our disclosure controls and procedures were not effective due to the material weakness described below.
+Added: our management, including our principal executive officer and principal financial officer, has concluded that, notwithstanding the identified
+Added: material weakness in our internal control over financial reporting, the financial statements in this Annual Report on Form 10-K fairly
+Added: present, in all material respects, our financial condition, results of operations and cash flows for the periods presented in conformity
+Added: Weakness in Internal Controls Over Financial Reporting
+Added: identified a material weakness in our internal control over financial reporting that exists as of December 31, 2022.
+Added: A material weakness
+Added: is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility
+Added: that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis.
+Added: We determined
+Added: that we had a material weakness because, due to our small size, and our limited number of personnel, we did not have in place an effective
+Added: internal control environment with formal processes and procedures, including journal entry processing and review, to allow for a detailed
+Added: review of accounting transactions that would identify errors in a timely manner.
+Added: Notwithstanding
+Added: the material weaknesses in our internal control over financial reporting, we have concluded that the consolidated financial statements
+Added: included in this Annual Report on Form 10-K fairly present, in all material respects, our financial position, results of operations and
+Added: cash flows for the periods presented in conformity with accounting principles generally accepted in the United States of America.
+Added: Plan to Remediate the Material Weakness
+Added: the oversight of senior management, we implemented remediation steps in 2021 including addition of accounting consultants and continue
+Added: to evaluate and implement procedures that will strengthen our internal controls.
+Added: We believe these measures will remediate the material
+Added: weakness identified and strengthen our internal control over financial reporting.
+Added: We are committed to continuing to improve our
+Added: internal control processes and will continue to diligently review our financial reporting controls and procedures.
Annual Report on Internal Control Over Financial Reporting and Auditor Attestation
−Removed: This Annual Report on Form 10-K does not include a report of management’s
−Removed: assessment regarding internal control over financial reporting due to a transition period established by the rules of the SEC for new
−Removed: public companies.
−Removed: In addition, this Annual Report on Form 10-K does not include an attestation report of our independent registered public
−Removed: accounting firm regarding internal control over financial reporting as an attestation is not required pursuant to the exemption provided
−Removed: to issuers that are not “large accelerated filers” nor “accelerated filers” under the Dodd-Frank Wall Street Reform
−Removed: and Consumer Protection Act.
+Added: Annual Report on Form 10-K does not include a report of management’s assessment regarding internal control over financial reporting
+Added: due to a transition period established by the rules of the SEC for new public companies.
+Added: In addition, this Annual Report on Form 10-K
+Added: does not include an attestation report of our independent registered public accounting firm regarding internal control over financial
+Added: reporting as an attestation is not required pursuant to the exemption provided to issuers that are not “large accelerated filers”
+Added: nor “accelerated filers” under the Dodd-Frank Wall Street Reform and Consumer Protection Act.
in Internal Control Over Financial Reporting
4 unchanged sentences
DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE
−Removed: The information required by this item is incorporated
−Removed: by reference to our Proxy Statement for the 2022 Annual Meeting of Stockholders to be filed with the Securities and Exchange Commission
−Removed: within 120 days of the fiscal year ended December 31, 2021.
+Added: information required by this item is incorporated by reference to our 2023 Proxy Statement for the 2023 Annual Meeting of Stockholders
+Added: to be filed with the SEC within 120 days of the fiscal year ended December 31, 2022.
EXECUTIVE COMPENSATION
−Removed: information required by this item is incorporated by reference to our Proxy Statement for the 2022 Annual Meeting of Stockholders to
−Removed: be filed with the Securities and Exchange Commission within 120 days of the fiscal year ended December 31, 2021.
+Added: information required by this item is incorporated by reference to our 2023 Proxy Statement for the 2023 Annual Meeting of Stockholders
+Added: to be filed with the SEC within 120 days of the fiscal year ended December 31, 2022.
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS
−Removed: information required by this item is incorporated by reference to our Proxy Statement for the 2022 Annual Meeting of Stockholders to
−Removed: be filed with the Securities and Exchange Commission within 120 days of the fiscal year ended December 31, 2021.
+Added: information required by this item is incorporated by reference to our 2023 Proxy Statement for the 2023 Annual Meeting of Stockholders
+Added: to be filed with the SEC within 120 days of the fiscal year ended December 31, 2022.
CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE
−Removed: information required by this item is incorporated by reference to our Proxy Statement for the 2022 Annual Meeting of Stockholders to
−Removed: be filed with the Securities and Exchange Commission within 120 days of the fiscal year ended December 31, 2021.
+Added: information required by this item is incorporated by reference to our 2023 Proxy Statement for the 2023 Annual Meeting of Stockholders
+Added: to be filed with the SEC within 120 days of the fiscal year ended December 31, 2022.
PRINCIPAL ACCOUNTANT FEES AND SERVICES
−Removed: information required by this item is incorporated by reference to our Proxy Statement for the 2022 Annual Meeting of Stockholders to
−Removed: be filed with the Securities and Exchange Commission within 120 days of the fiscal year ended December 31, 2021.
−Removed: EXHIBITS, FINANCIAL STATEMENT SCHEDULES
+Added: information required by this item is incorporated by reference to our 2023 Proxy Statement for the 2023 Annual Meeting of Stockholders
+Added: to be filed with the SEC within 120 days of the fiscal year ended December 31, 2022.
+Added: EXHIBITS AND FINANCIAL STATEMENT SCHEDULES
following documents are filed as part of this report:
−Removed: Index to Consolidated Financial Statements:
+Added: to Consolidated Financial Statements:
Financial Statements:
−Removed: Report of the Independent Registered Public Accounting Firm
+Added: Report of the Independent Registered Public Accounting Firm (PCAOB ID:
Consolidated Balance Sheets as of December 31, 2022 and 2021
Consolidated Statements of Operations and Comprehensive Loss for the years ended December 31, 2022 and 2021
−Removed: Consolidated Statements of Stockholders’ Equity (Deficit) for the years ended December 31, 2021 and 2020
+Added: Consolidated Statements of Stockholders’ Equity for the years ended December 31, 2022 and
Consolidated Statements of Cash Flows for the years ended December 31, 2022 and 2021
7 unchanged sentences
Description of the Registrant’s Securities
+Added: Form of Senior Indenture (Incorporated by reference to Exhibit 4.3 to the Company’s Registration Statement on Form S-3 filed with the SEC on January 3, 2023)
+Added: Form of Subordinated Indenture (Incorporated by reference to Exhibit 4.4 to the Company’s Registration Statement on Form S-3 filed with the SEC on January 3, 2023)
2021 Equity Incentive Plan (Incorporated by reference to Exhibit 10.1 to the Company’s Registration Statement on Form S-1/A filed with the SEC on October 6, 2021)
6 unchanged sentences
Clinical Collaboration and Supply Agreement by and between the Company and BeiGene Switzerland GmbH dated August 20, 2021 (Incorporated by reference to Exhibit 10.8 to the Company’s Registration Statement on Form S-1/A filed with the SEC on October 15, 2021)
+Added: Amendment to Employment Agreement by and between the Company and Ilya Rachman dated as of November 9, 2022 (Incorporated by reference to Exhibit 10.1 to the Company’s Quarterly Report on Form 10-Q filed with the SEC on November 9, 2022)
+Added: Amendment to Master Services Agreement by and between the Company and Alwaysraise, LLC dated as of November 9, 2022 (Incorporated by reference to Exhibit 10.2 to the Company’s Quarterly Report on Form 10-Q filed with the SEC on November 9, 2022)
+Added: Research and License Agreement entered into on December 8, 2022 by and between Nexcella, Inc.
+Added: (formerly Immix Biopharma Cell Therapy, Inc.), Hadasit Medical Research Services & Development, Ltd.
+Added: and BIRAD Research and Development Company Ltd.
+Added: (Incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the SEC on December 14, 2022)
+Added: Form of Share Purchase Agreement (Incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the SEC on January 18, 2023)
+Added: Senior Unsecured Promissory Note issued by Nexcella, Inc.
+Added: to Immix Biopharma, Inc.
+Added: on December 21, 2022
2016 Equity Incentive Plan (Incorporated by reference to Exhibit 10.4 to the Company’s Registration Statement on Form S-1/A filed with the SEC on October 6, 2021)
−Removed: Code of Business Conduct and Ethics
+Added: Code of Business Conduct and Ethics (Incorporated by reference to Exhibit 14.1 to the Company’s Annual Report on Form 10-K filed with the SEC on March 28, 2022)
Consent of KMJ Corbin & Company LLP, independent registered public accounting firm
5 unchanged sentences
XBRL Instance Document
−Removed: Inline XBRL Taxonomy Extension
−Removed: Schema Document
−Removed: Inline XBRL Taxonomy Extension
−Removed: Calculation Linkbase Document
−Removed: Inline XBRL Taxonomy Extension
−Removed: Label Linkbase Document
−Removed: Inline XBRL Taxonomy Extension
−Removed: Presentation Linkbase Document
−Removed: Inline XBRL Taxonomy Extension
−Removed: Definition Linkbase Document
+Added: XBRL Taxonomy Extension Schema Document
+Added: XBRL Taxonomy Extension Calculation Linkbase Document
+Added: XBRL Taxonomy Extension Label Linkbase Document
+Added: XBRL Taxonomy Extension Presentation Linkbase Document
+Added: XBRL Taxonomy Extension Definition Linkbase Document
Page Interactive Data File – the cover page of the Registrant’s Annual Report on Form 10-K for the year ended December
1 unchanged sentence
Filed herewith.
+Added: ** Furnished herewith.
Management contract or compensatory plan or arrangement.
−Removed: Pursuant to Item 601(b)(10) of Regulation S-K, certain
−Removed: confidential portions of this exhibit were omitted by means of marking such portions with an asterisk because the identified confidential
−Removed: portions (i) are not material and (ii) would be competitively harmful if publicly disclosed.
+Added: Pursuant to Item 601(b)(10) of Regulation S-K, certain confidential portions of this exhibit were omitted by means of marking such portions
+Added: with an asterisk because the Company customarily and actually treats such information as private
+Added: or confidential and such omitted information is not material.
FORM 10-K SUMMARY
14 unchanged sentences
Gabriel Morris
−Removed: Financial Officer
−Removed: Financial and Accounting Officer) and Director
+Added: Financial Officer and Director
+Added: Financial and Accounting Officer)
Magda Marquet
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.